Suntril Pharmaceuticals Private Limited, a active private limited company, was established on 29 November 2013 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232CH2013PTC034849. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹2.20 Cr and a paid-up capital of ₹2.20 Cr.
It upholds a compliant status. Employing 18 professional, Its leadership includes Trilok Chand Narula (Additional Director), Pardeep Narula (Managing Director). Past directors included Leena Rana. It holds ₹4.52 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H No. 124/1 Sector 45 A, Chandigarh, Chandigarh, 160045.
U24232CH2013PTC034849
034849
29 November 2013
₹2.20 Cr
₹2.20 Cr
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Suntril Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Trilok Chand Narula | Additional Director | 13 Apr 2015 | Current |
| Pardeep Narula | Managing Director | 29 Nov 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Apr 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Suntril Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 50.91% increase. The company also saw a substantial improvement in profitability, with a 184.06% increase in profit. The company's net worth Soared by an impressive increase of 204.83%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Suntril Pharmaceuticals had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹45,208,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Nov 2021 | Bank Of India | ₹3.77 M | Open |
| 15 Sep 2015 | Bank Of India | ₹4.14 Cr | Open |
Explore comprehensive loan charge details -
Suntril Pharmaceuticals has a workforce of 18 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Suntril Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suntril Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Suntril Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Suntril Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was recorded as a recent event.
The activity A charge with Bank Of India amounted to Rs. 0.38 Cr with Charge ID 100513484 was registered on 25 Nov 2021. was completed.
The activity A charge with Bank Of India of Rs. 4.14 Cr registered on 15 Sep 2015 with Charge ID 10597325 was modified on 14 Aug 2020. was completed.
A charge with Bank Of India amounted to Rs. 4.14 Cr with Charge ID 10597325 was registered on 15 Sep 2015. was recorded as a recent event.
Progress on Trilok Chand Narula was appointed as a Additional Director was appointed as a Additional Director on 13 Apr 2015 & has been associated with this company since 10 years 8 months . was documented.
The CIN of Suntril Pharmaceuticals Private Limited is U24232CH2013PTC034849.
Suntril Pharmaceuticals Private Limited is headquartered at H No. 124/1 Sector 45 A, Chandigarh, Chandigarh, 160045.
Suntril Pharmaceuticals Private Limited was incorporated on 29 November 2013.
The current directors of Suntril Pharmaceuticals Private Limited are
The primary industry of Suntril Pharmaceuticals Private Limited is Manufacturing.
Suntril Pharmaceuticals Private Limited is unlisted.
The authorized capital of Suntril Pharmaceuticals Private Limited is ₹2.20 Cr, and the paid-up capital is ₹2.20 Cr.
The compliance status of Suntril Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX